HDAC3 inhibitors induce drug resistance by promoting IL-17 A production by T cells
Abstract HDAC3 has been demonstrated to play a crucial role in the progression of various tumors and the differentiation and development of T cells. However, its impact on peripheral T cells in the development of murine lung cancer remains unclear. In this experiment, a subcutaneous lung tumor model...
Saved in:
Main Authors: | Hao Chen, Anqi Qin, Fan Xu, Shuai Guo, Ge Zhang, Aihong Zhang, WenTing Li, Feng Tian, Quanhui Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-024-83447-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies
by: Wanli Zhang, et al.
Published: (2025-02-01) -
Loss of Notch dimerization perturbs intestinal homeostasis by a mechanism involving HDAC activity.
by: Quanhui Dai, et al.
Published: (2024-12-01) -
Staphylococcus aureus induces mitophagy via the HDAC11/IL10 pathway to sustain intracellular survival
by: Yaji Yang, et al.
Published: (2025-02-01) -
Chidamide Suppresses the Growth of Cholangiocarcinoma by Inhibiting HDAC3 and Promoting FOXO1 Acetylation
by: Yongpan Li, et al.
Published: (2022-01-01) -
Exosomal circ_0006896 promotes AML progression via interaction with HDAC1 and restriction of antitumor immunity
by: Can Can, et al.
Published: (2025-01-01)